Wenwen L. Zhang

Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Image-Guided Adaptive Brachytherapy Using Patient-Specific 3D-Printed Templates for Complex Locally Advanced Cervical Cancer: A Real-World Implementation Study.

Image-Guided Adaptive Brachytherapy Using Patient-Specific 3D-Printed Templates for Complex Locally Advanced Cervical Cancer: A Real-World Implementation Study.

Journal: Cancers

Published: June 30, 2026

Correction: CS Ratio is an immune-related prognostic biomarker for cervical cancer.

Correction: CS Ratio is an immune-related prognostic biomarker for cervical cancer.

Journal: Frontiers in oncology

Published: September 02, 2025

Impact of single-site distant metastases on prognosis in advanced ovarian cancer: a Surveillance, Epidemiology, and End Results population-based study.

Impact of single-site distant metastases on prognosis in advanced ovarian cancer: a Surveillance, Epidemiology, and End Results population-based study.

Journal: Translational cancer research

Published: June 24, 2025

USP43-mediated HSPA8 deubiquitination alleviates diabetic kidney disease.

USP43-mediated HSPA8 deubiquitination alleviates diabetic kidney disease.

Journal: Biochemical and biophysical research communications

Published: May 28, 2025

Promoting tumor cell secretion of IL18 to induce reprogramming of tumor-associated macrophages - The novel anticancer mechanism of anlotinib in ovarian cancer.

Promoting tumor cell secretion of IL18 to induce reprogramming of tumor-associated macrophages - The novel anticancer mechanism of anlotinib in ovarian cancer.

Journal: Biochemical pharmacology

Published: January 16, 2025

The development and validation of a novel programmed cell death-related signature based on machine learning analysis of 15 programmed cell death patterns for predicting prognosis and therapeutic response in high-grade serous ovarian carcinoma.

The development and validation of a novel programmed cell death-related signature based on machine learning analysis of 15 programmed cell death patterns for predicting prognosis and therapeutic response in high-grade serous ovarian carcinoma.

Journal: Translational cancer research

Published: December 30, 2024

A feasibility study of automating radiotherapy planning with large language model agents.

A feasibility study of automating radiotherapy planning with large language model agents.

Journal: Physics in medicine and biology

Published: December 21, 2024

CS Ratio is an immune-related prognostic biomarker for cervical cancer.

CS Ratio is an immune-related prognostic biomarker for cervical cancer.

Journal: Frontiers in oncology

Published: December 18, 2024

A systematic CRISPR screen reveals an NBL1-mediated Jak/Stat3 crosstalk to promote ovarian cancer metastasis.

A systematic CRISPR screen reveals an NBL1-mediated Jak/Stat3 crosstalk to promote ovarian cancer metastasis.

Journal: Genes & diseases

Published: November 21, 2024

CAUSALdb2: an updated database for causal variants of complex traits.

CAUSALdb2: an updated database for causal variants of complex traits.

Journal: Nucleic acids research

Published: September 08, 2024

Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer.

Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer.

Journal: Open medicine (Warsaw, Poland)

Published: August 30, 2024

Hydroxypropyl-β-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunity.

Hydroxypropyl-β-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunity.

Journal: International immunopharmacology

Published: August 15, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026